Cite

HARVARD Citation

    Harding, J. et al. (2020). Phase Ib Study of Enzalutamide with or Without Sorafenib in Patients with Advanced Hepatocellular Carcinoma. Oncologist. pp. e1825-e1836. [Online]. 
  
Back to record